Conference Agenda
January 5, 2019
7:00 a.m. – 8:00 a.m. Registration and Continental Breakfast with Exhibitors
8:00 a.m – 8:15 a.m. Welcome & AAN Updates
8:15 a.m. – 9:15 a.m. Utilizing Advanced Science to Improve the Quality of Life in Patients with Parkinson’s Disease
9:15 a.m. – 10:45 a.m. Immune Dysfunction in Multiple Sclerosis: CMS Modern Considerations in Treatment and Management
10:45 a.m. – 11:00 a.m. Coffee Break with Exhibitors
11:00 a.m. – 11:30 a.m. Headache Therapy: 2019 Update
11:30 a.m. – 12:00 p.m. VNS Programming
12:00 p.m. – 12:45 p.m. Headache Procedure Workshop / VNS Demos
12:45 p.m. – 1:30 p.m. Lunch with Exhibitors and MLMIC Update
1:30 p.m. – 2:15 p.m. An Overview and Update on Medical Cannabis
2:15 p.m. – 3:00 p.m. Stroke Update
3:00 p.m. – 3:45 p.m. Telemedicine Update
3:45 p.m. – 4:00 p.m. Coffee Break with Exhibitors
4:00 p.m. – 5:15 p.m. Neurostakes Residency Competition
5:15 p.m. – 6:15 p.m. BRAINPAC Cocktail Reception (All welcome!)
*Utilizing Advanced Science to Improve the Quality of Life in Patients with Parkinson’s Disease* This portion of the agenda is a CME Category I Program provided by AcademicCME *This activity is supported by an educational grant from Acorda* AcademicCME is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. AcademicCME designates this live material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
*Immune Dysfunction in Multiple Sclerosis: CMS Modern Considerations in Treatment and Management* This portion of the agenda is provided by the Consortium of Multiple Sclerosis Centers (CMSC), International Organization of Multiple Sclerosis Nurses (IOMSN), and Catamount Medical Education and supported by educational grants from Biogen, EMD Serono, Genzyme, and Novartis Pharmaceuticals Corporation.
In support of improving patient care, this activity has been planned and implemented by the CMSC, IOMSN, and Catamount Medical Education. CMSC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. For CE information, including statements of credit, please visit Catamount CME for Immune Dysfunction in MS.
Headache Therapy: 2019 Update; VNS Programming; Headache and VNS Demo Sessions; An Overview and Update on Medical Cannabis; Stroke Update; Telemedicine Update. This portion of the agenda is a CME Category I Program provided by MLMIC. This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Medical Society of the State of New York (MSSNY) through the joint providership of MLMIC Insurance Company (MLMIC) and the New York State Neurological Society. MLMIC is accredited by MSSNY to provide continuing medical education for physician. MLMIC designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
6.5 Category 1 CME Credits
Register for the NYSNS Annual Winter Meeting Today January 5, 2019
Join us at the NY State Neurological Society’s Annual Winter Meeting on
Saturday, January 5, 2019 at New York City’s Stewart Hotel, 371 Seventh Avenue at 31 Street, right across from Penn Station.
Questions? Email NY State Neurological Society
For Preferred Stewart Hotel Room Rates for the Meeting, REGISTER BY DECEMBER 5, 2018
Register at the Stewart Hotel BY DECEMBER 5, 2018 to get the preferred rate:
Register Here for the Stewart Hotel
Here’s the VERY Latest Program Details for January 5, 2019!
Here’s the VERY Latest Program Details!
*Utilizing Advanced Science to Improve the Quality of Life in Patients with Parkinson’s Disease* with Fiona Gupta, MD, The Mt. Sinai Hospital, Assistant Professor of Neurology
The above portion of the agenda is a CME Category I Program provided by AcademicCME *This activity is supported by an educational grant from Acorda* AcademicCME is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. AcademicCME designates this live material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
*Immune Dysfunction in Multiple Sclerosis: CMS Modern Considerations in Treatment and Management*
The above portion of the agenda is provided by the Consortium of Multiple Sclerosis Centers (CMSC), International Organization of Multiple Sclerosis Nurses (IOMSN), and Catamount Medical Education and supported by educational grants from Biogen, EMD Serono, Genzyme, and Novartis Pharmaceuticals Corporation. In support of improving patient care, this activity has been planned and implemented by the CMSC, IOMSN, and Catamount Medical Education. CMSC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. For CE information, including statements of credit, please visit Catamount CME for Immune Dysfunction in MS.
Headache Therapy Update with Matthew S. Robbins, MD, Neurology Residency Program Director, Weill Cornell Medicine and New York Presbyterian Hospital.
New Treatments in Epilepsy with Robert Glover, MD, Clinical Assistant Professor, Department of Neurology, University of Buffalo, Jacobs School of Medicine and Biomedical Sciences
Headache Procedure Workshop / VNS Demos with Doctor Robbins and Joshua M. Cohen, MD, MPH, Global Therapeutic Area Lead for Migraine & Headache, Teva Pharmaceuticals; and Doctor Glover and Mill Etienne, MD, MPH, FAAN, Director of the Epilepsy and EEG Laboratory at Good Samaritan Regional Medical Center, and Assistant Professor of Neurology at New York Medical College.
An Overview and Update on Medical Cannabis with Laszlo L. Mechtler, MD, Medical Director, Dent Neuorlogic Institute, Professor of Neuorology and Neuro-Oncology, State University of New York at Buffalo
Stroke Update with Shazia Alam, DO, Director, Neurohospitalist & Stroke Services, NYU Winthrop Hospital
Telemedicine Update with Eric R. Anderson, MD, PhD, Director of Telemedicine, Corticare
*Category I CME Program*
January 5, 2019 for The Annual NYSNS Winter Meeting
SAVE THE DATE of January 5, 2019, in New York City for the Annual NYSNS Winter Meeting.
Join us at New York City’s Stewart Hotel
371 7 Avenue at 31 Street
Crucial Updates on
Parkinson’s, MS, Headache Therapy, Stroke, More
Don’t Forget Your Favorite Resident Competition: The Neurostakes!
Exhibiting at the Conference
If you are a company that wishes to host an exhibit at the conference, please email nysneurology@gmail.com for more information.
$2,500 FRIEND
One Exhibitor and One Table
One Conference Registration Guest
$5,000 COPPER
One Exhibitor and One Table
Two Conference Registration Guests
Breakfast Sponsor
$7,500 SILVER
One Exhibitor and One Table
Three Conference Registration Guests
Resident/Fellow Scholarship Sponsor
$10,000 GOLD
Two Exhibitors and Two Tables
Five Conference Registration Guests
Second Choice of Space
One Targeted Email Blast to Membership in 2019
NEUROSTAKES Named Sponsor (Resident Team Quiz Show)
$17,500 PLATINUM
Two Exhibitors and Two Tables
Ten Conference Registration Guests
First Choice of Space
Two Targeted Email Blast to Membership in 2019
Lanyard Sponsorship
Folder Sponsorship
Sole Lunch Sponsorship
Wifi Sponsor
